This proposed Tropical Medicine Research Center proposes to unify a multi-national group of investigators studying critical aspects of the fatal disease, visceral leishmaniasis in Bihar State, India. The region has the highest endemic rate of visceral leishmaniasis in India, and one of the highest rates of visceral leishmaniasis worldwide. Coordination of the project will be focused at Banaras Hindu University (BHU) in Varanasi, India. Major collaborators are found at the University of Cambridge, UK, the Institute of Tropical Medicine in Antwerp, Belgium, the National Institutes of Health in Washington, DC, USA, and the University of Iowa, USA. The TMRC will be administered primarily at BHU. A satellite administrative core will be maintained at the University of Iowa, USA. BHU is the site where most laboratory research activities take place, and where most epidemiological and GIS data are analyzed. The main data management center will also be at BHU. Because of the international collaborative activities associated with this program, with collaborators in the U.S.A., the U.K, and Belgium, some administrative functions will be orchestrated through the University of Iowa.
Specific aims of the program are: 1. To handle financial aspects of the TMRC. This includes administration of funds used for research, administration and data management in India, as well as subcontracts to the University of Iowa, the University of Cambridge, Westat, and the Institute of Tropical Medicine, Belgium. 2. To obtain equipment and research supplies for the two research sites in India, to orchestrate submission of publications, and to arrange communications. 3. To make arrangements for foreign visitors from the USA, the UK, and Belgium. 4. To arrange the annual TMRC meeting, and annual meetings of the TMRC members in Bethesda at annual meetings in the USA.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center (P50)
Project #
1P50AI074321-01
Application #
7285462
Study Section
Special Emphasis Panel (ZAI1-GSM-M (J1))
Project Start
2007-07-01
Project End
2012-07-31
Budget Start
2007-07-01
Budget End
2008-07-31
Support Year
1
Fiscal Year
2007
Total Cost
$96,650
Indirect Cost
Name
Banaras Hindu University
Department
Type
DUNS #
650330558
City
Varanasi
State
Country
India
Zip Code
22100-5
Singh, Toolika; Fakiola, Michaela; Oommen, Joyce et al. (2018) Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis. J Immunol 200:2727-2737
Sundar, Shyam; Singh, Anup (2018) Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology 145:481-489
Sundar, Shyam; Singh, Bhawana (2018) Emerging therapeutic targets for treatment of leishmaniasis. Expert Opin Ther Targets 22:467-486
Sundar, Shyam; Singh, Bhawana (2018) Understanding Leishmania parasites through proteomics and implications for the clinic. Expert Rev Proteomics 15:371-390
Sundar, Shyam; Agarwal, Dipti (2018) Visceral Leishmaniasis-Optimum Treatment Options in Children. Pediatr Infect Dis J 37:492-494
Singh, Neetu; Sundar, Shyam (2018) Combined neutralization of interferon gamma and tumor necrosis factor alpha induces IL-4 production but has no direct additive impact on parasite burden in splenic cultures of human visceral leishmaniasis. PLoS One 13:e0199817
Singh, Neetu; Kumar, Rajiv; Chauhan, Shashi Bhushan et al. (2018) Peripheral Blood Monocytes With an Antiinflammatory Phenotype Display Limited Phagocytosis and Oxidative Burst in Patients With Visceral Leishmaniasis. J Infect Dis 218:1130-1141
Kelly, Patrick H; Bahr, Sarah M; Serafim, Tiago D et al. (2017) The Gut Microbiome of the Vector Lutzomyia longipalpis Is Essential for Survival of Leishmania infantum. MBio 8:
Sharma, Smriti; Srivastva, Shweta; Davis, Richard E et al. (2017) The Phenotype of Circulating Neutrophils during Visceral Leishmaniasis. Am J Trop Med Hyg 97:767-770
Kansal, S; Chakravarty, J; Kumar, A et al. (2017) Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India. Trop Med Int Health 22:1037-1042

Showing the most recent 10 out of 90 publications